Tempur Sealy International, Inc. — Q1 2024 Form 10-Q
Business context and period. The supplied filing is for Tempur Sealy International, Inc. (NYSE: TPX), not Somnigroup International Inc. It covers the three months ended March 31, 2024. The company designs, manufactures, distributes and sells bedding products through Wholesale and Direct channels, in North America and International segments.
Financial results
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net sales | $1,189.4 million | $1,208.1 million |
| Gross profit / margin | $512.6 million / 43.1% | $499.9 million / 41.4% |
| Operating income / margin | $131.5 million / 11.1% | $143.3 million / 11.9% |
| Net income attributable to the company | $76.3 million | $85.3 million |
| Diluted EPS | $0.43 | $0.48 |
| Operating cash flow | $130.2 million | $99.8 million |
| Capital expenditures | $31.5 million | $52.1 million |
- Revenue fell 1.5% reported and 2.1% on a constant-currency basis. North America sales declined 2.0%; International sales were nearly flat reported, but down 1.6% constant currency.
- Gross margin expanded 170 basis points, reflecting favorable commodity costs and manufacturing efficiencies. Operating income declined 8.2%; expenses rose 6.9%, including higher growth-investment spending and $14.8 million of Mattress Firm transaction costs.
- Adjusted operating income was $149.4 million, down 2.6%; adjusted net income was $89.7 million, down 3.4%; adjusted diluted EPS was $0.50, down 5.7%. These are non-GAAP measures; reported results include the adjustments described below.
- Cash and cash equivalents were $92.5 million at quarter-end, versus $74.9 million at December 31, 2023. Net working capital was $203.7 million. Operating cash flow improved by $30.4 million year over year, primarily due to changes in operating assets and liabilities.
- Total debt was $2,594.4 million, essentially unchanged from year-end; balance-sheet long-term debt, net, was $2,526.4 million. Revolver availability was $1,012.4 million, and total reported liquidity was $1,104.9 million. Net leverage under the credit agreement was 2.85x adjusted EBITDA; the maximum is 5.00x. The company reported compliance with its debt covenants.
Material changes and notable items
- North America Wholesale sales decreased 3.4%, while North America Direct sales increased 7.7%, led by e-commerce. International Direct sales declined 3.2% on a constant-currency basis.
- Consolidated operating expenses increased $24.8 million. Corporate expenses rose $10.8 million, primarily due to Mattress Firm transaction costs; operating expenses also increased in both segments from growth initiatives.
- Interest expense increased 4.6% to $34.3 million, primarily because of higher rates on variable-rate debt. The effective tax rate was 21.2%, compared with 22.2%.
- Q1 2024 non-GAAP adjustments included $14.8 million of acquisition-related transaction costs and $3.1 million of manufacturing-capacity start-up costs. Q1 2023 adjustments included $5.2 million of transaction costs, $1.7 million of start-up costs, and $3.2 million of ERP transition costs.
- Q1 financing cash flows included $43.8 million of treasury stock activity for shares withheld to cover equity-award taxes; the company said it made no repurchases under its share repurchase program during the quarter.
Outlook, risks and contingencies
- Management expects 2024 capital expenditures of approximately $150 million, including $110 million of maintenance spending. It said operating cash flow, cash on hand and credit availability should meet foreseeable funding needs.
- The company expects Mattress Firm’s approximately $4.0 billion acquisition to close in the second half of 2024, subject to customary conditions, including regulatory approvals. The announced consideration is approximately $2.7 billion cash and 34.2 million shares. A February 2024 credit amendment added a $625 million delayed-draw term loan and $40 million of revolver availability for the financing strategy.
- Management expects continued inflation and interest-rate pressure on consumers and ongoing geopolitical uncertainty, but anticipates outperforming the bedding industry, citing product launches and U.S. distribution gains. Planned launches include a new North America Tempur-Pedic Adapt portfolio and broader rollout of Tempur products internationally.
- Key disclosed risks include consumer and industry weakness, raw-material and labor costs, supply disruption, competition, acquisition approval and execution, cybersecurity and IT resilience, foreign exchange and interest rates, litigation and tax matters, and debt covenant compliance. The filing discusses $14.3 million of cybersecurity-event costs in the trailing 12 months, including manufacturing/network disruption and incident-response expenses. Management reported no material change in market-risk disclosures and no material adverse effect expected from pending legal proceedings in aggregate.
- The board declared a $0.13-per-share dividend payable May 30, 2024. The company said it temporarily suspended program share repurchases ahead of the Mattress Firm transaction.
Important facts for investors to verify
- Confirm the issuer identity: the supplied 10-Q is Tempur Sealy International, Inc., despite the request metadata naming Somnigroup International Inc.
- Track Mattress Firm regulatory approval, closing timing, final financing terms, share issuance and integration or synergy expectations.
- Assess whether margin gains from commodity costs and operational efficiencies can persist while sales remain pressured and operating expenses grow.
- Monitor variable-rate borrowing costs, debt levels, covenant headroom, liquidity and the planned capital-spending program.
- Review the company’s non-GAAP reconciliations and the continuing operational and financial effects of the 2023 cybersecurity incident.